A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine. Rates of precancerous lesions in women between the ages of 20 and 24 dropped by roughly 80 percent from 2008 to 2022,

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually transmitted infection that affects both females and males and is linked to higher risks of various forms of cancer.

Despite RFK Jr.'s claims, CDC data shows the HPV vaccine reduces cervical precancers by 80% in young women, highlighting its effectiveness in cancer prevention.

(AP Photo/Charles Rex Arbogast, File) A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary Robert F. Kennedy Jr., is ...

A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary Robert F. Kennedy Jr., is preventing cervical cancer in young women.

In the United States, human papillomavirus (HPV) is the most common sexually transmitted infection, according to the CDC | Microbiology

A new study published Thursday by researchers at the US Centers for Disease Control and Prevention (CDC) highlights the powerful impact of the human papillomavirus (HPV) vaccine, first approved in 2006,

A new government report shows an 80% decrease in cervical precancerous lesions among vaccinated young women. Despite previous criticisms from Health Secretary Robert F. Kennedy Jr., the HPV vaccine proves effective in preventing cervical cancer.

The immunization schedule protects against 14 potentially serious diseases before a child’s second birthday, as recommended by the CDC.